M.M. Muresan, P. Olivier, J. Leclère, F. Sirveaux, L. Brunaud, M. Klein, R. Zarnegar, G. Weryha, Bone metastases from differentiated thyroid carcinoma. Endocr. Relat. Cancer. 15, 37–49 (2008). https://doi.org/10.1677/ERC-07-0229

Article  CAS  PubMed  Google Scholar 

B.R. Haugen, E.K. Alexander, K.C. Bible, G.M. Doherty, S.J. Mandel, Y.E. Nikiforov, F. Pacini, G.W. Randolph, A.M. Sawka, M. Schlumberger, K.G. Schuff, S.I. Sherman, J.A. Sosa, D.L. Steward, R.M. Tuttle, L. Wartofsky, 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 26, 1–133 (2016). https://doi.org/10.1089/THY.2015.0020

Article  PubMed  PubMed Central  Google Scholar 

A. Jannin, L. Lamartina, C. Moutarde, M. Djennaoui, G. Lion, B. Chevalier, M.C. Vantyghem, F. Deschamps, J. Hadoux, E. Baudin, M. Schlumberger, S. Leboulleux, C. Do Cao, Bone metastases from differentiated thyroid carcinoma: heterogenous tumor response to radioactive Iodine therapy and overall survival. Eur. J. Nucl. Med. Mol. Imaging. 49, 2401–2413 (2022). https://doi.org/10.1007/s00259-022-05697-w

Article  CAS  PubMed  PubMed Central  Google Scholar 

C. Durante, N. Haddy, E. Baudin, S. Leboulleux, D. Hartl, J.P. Travagli, B. Caillou, M. Ricard, J.D. Lumbroso, F. De Vathaire, M. Schlumberger, Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: Benefits and limits of radioiodine therapy. J. Clin. Endocrinol. Metab. 91, 2892–2899 (2006). https://doi.org/10.1210/jc.2005-2838

Article  CAS  PubMed  Google Scholar 

G. Mazziotti, A.M. Formenti, M.B. Panarotto, E. Arvat, A. Chiti, A. Cuocolo, M.E. Dottorini, C. Durante, L. Agate, S. Filetti, F. Felicetti, A. Filice, L. Pace, T. Pellegrino, M. Rodari, M. Salvatori, C. Tranfaglia, A. Versari, D. Viola, S. Frara, A. Berruti, A. Giustina, R. Giubbini, Real-life management and outcome of thyroid carcinoma-related bone metastases: results from a nationwide multicenter experience. Endocrine 59, 90–101 (2018). https://doi.org/10.1007/s12020-017-1455-6

Article  CAS  PubMed  Google Scholar 

R. Paschke, T. Lincke, S.P. Müller, M.C. Kreissl, H. Dralle, M. Fassnacht, The treatment of well differentiated thyroid carcinoma. Dtsch. Arztebl. Int. 112, 452–458 (2015). https://doi.org/10.3238/arztebl.2015.0452

Article  PubMed  PubMed Central  Google Scholar 

J. Lee, E.Y. Soh, Differentiated thyroid carcinoma presenting with distant metastasis at initial diagnosis: Clinical outcomes and prognostic factors. Ann. Surg. 251, 114–119 (2010). https://doi.org/10.1097/SLA.0b013e3181b7faf6

Article  PubMed  Google Scholar 

M. Steinschneider, J. Pitaro, S. Koren, Y. Mizrakli, C. Benbassat, L.M. Kalmovich, Differentiated thyroid cancer with biochemical incomplete response: Clinico-pathological characteristics and long term disease outcomes. Cancers (Basel) 13, 1–9 (2021). https://doi.org/10.3390/cancers13215422

Article  CAS  Google Scholar 

F. Vaisman, H. Tala, R. Grewal, R.M. Tuttle, In differentiated thyroid cancer, an incomplete structural response to therapy is associated with significantly worse clinical outcomes than only an incomplete thyroglobulin response. Thyroid 21, 1317–1322 (2011). https://doi.org/10.1089/thy.2011.0232

Article  CAS  PubMed  Google Scholar 

J. Ahn, E. Song, W.G. Kim, T.Y. Kim, W.B. Kim, Y.K. Shong, M.J. Jeon, Long-term clinical outcomes of papillary thyroid carcinoma patients with biochemical incomplete response. Endocrine 67, 623–629 (2020). https://doi.org/10.1007/s12020-019-02142-1

Article  CAS  PubMed  Google Scholar 

A.S. Alzahrani, Y. Moria, N. Mukhtar, H. Aljamei, S. Mazi, L. Albalawi, A. Aljomaiah, Course and predictive factors of incomplete response to therapy in low- and intermediate-risk thyroid cancer. J. Endocr. Soc. 5, 1–10 (2021). https://doi.org/10.1210/jendso/bvaa178

Article  Google Scholar 

S. Filetti, C. Durante, D. Hartl, S. Leboulleux, L.D. Locati, K. Newbold, M.G. Papotti, A. Berruti, Thyroid cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 30, 1856–1883 (2019). https://doi.org/10.1093/annonc/mdz400

Article  CAS  PubMed  Google Scholar 

A. Lipton, K. Fizazi, A.T. Stopeck, D.H. Henry, M.R. Smith, N. Shore, M. Martin, S. Vadhan-Raj, J.E. Brown, G.E. Richardson, F. Saad, D.A. Yardley, K. Zhou, A. Balakumaran, A. Braun, Effect of denosumab versus zoledronic acid in preventing skeletal-related events in patients with bone metastases by baseline characteristics. Eur. J. Cancer. 53, 75–83 (2016). https://doi.org/10.1016/j.ejca.2015.09.011

Article  CAS  PubMed  Google Scholar 

G. Zettinig, B.J. Fueger, C. Passler, K. Kaserer, C. Pirich, R. Dudczak, B. Niederle, Long‐term follow‐up of patients with bone metastases from differentiated thyroid carcinoma – surgery or conventional therapy? Clin. Endocrinol. (Oxf). 56, 377–382 (2002). https://doi.org/10.1046/j.1365-2265.2002.01482.x

Article  PubMed  Google Scholar 

M. Schlumberger, C. Challeton, F. De Vathaire, J.P. Travagli, P. Gardet, J.D. Lumbroso, C. Francese, F. Fontaine, M. Ricard, C. Parmentier, Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma. J. Nucl. Med. 37, 598–605 (1996)

CAS  PubMed  Google Scholar 

C.A.G. Proye, D.H.R. Dromer, B.M. Carnaille, A.J.P. Gontier, A. Goropoulos, P. Carpentier, J. Lefebvre, M. Decoulx, J.L. Wemeau, P. Fossati, C. Sulman, Is it still worthwhile to treat bone metastases from differentiated thyroid carcinoma with radioactive iodine? World J. Surg. 16, 640–645 (1992). https://doi.org/10.1007/BF02067343

Article  CAS  PubMed  Google Scholar 

T. Petrich, A. Widjaja, T.J. Musholt, M. Hofmann, T. Brunkhorst, C. Ehrenheim, G. Oetting, W.H. Knapp, Outcome after radioiodine therapy in 107 patients with differentiated thyroid carcinoma and initial bone metastases: Side-effects and influence of age. Eur. J. Nucl. Med. 28, 203–208 (2001). https://doi.org/10.1007/s002590000420

Article  CAS  PubMed  Google Scholar 

Z.L. Qiu, H.J. Song, Y.H. Xu, Q.Y. Luo, Efficacy and survival analysis of 131I therapy for bone metastases from differentiated thyroid cancer. J. Clin. Endocrinol. Metab. 96, 3078–3086 (2011). https://doi.org/10.1210/jc.2011-0093

Article  CAS  PubMed  Google Scholar 

C.S. Kumar, D. Shanmugam, R. Venkatapathy, M. Ahmed, I. Munshi, Metastatic follicular carcinoma of thyroid in maxilla. Dental. Res. J. (Isfahan) 10, 817–819 (2013)

I. Califano, S. Deutsch, A. Löwenstein, C. Cabezón, F. Pitoia, Outcomes of patients with bone metastases from differentiated thyroid cancer. Arch. Endocrinol. Metab. 62, 14–20 (2018). https://doi.org/10.20945/2359-3997000000004

Article  PubMed  PubMed Central  Google Scholar